ALVO
Price
$8.12
Change
-$0.46 (-5.36%)
Updated
Sep 25 closing price
Capitalization
2.53B
47 days until earnings call
BNXTF
Price
$0.63
Change
-$0.02 (-3.08%)
Updated
Sep 24 closing price
Capitalization
75.47M
Interact to see
Advertisement

ALVO vs BNXTF

Header iconALVO vs BNXTF Comparison
Open Charts ALVO vs BNXTFBanner chart's image
Alvotech
Price$8.12
Change-$0.46 (-5.36%)
Volume$301.73K
Capitalization2.53B
BIONXT SOLUTIONS
Price$0.63
Change-$0.02 (-3.08%)
Volume$100
Capitalization75.47M
ALVO vs BNXTF Comparison Chart in %
Loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVO vs. BNXTF commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a StrongBuy and BNXTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (ALVO: $8.12 vs. BNXTF: $0.63)
Brand notoriety: ALVO and BNXTF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 74% vs. BNXTF: 2%
Market capitalization -- ALVO: $2.53B vs. BNXTF: $75.47M
ALVO [@Pharmaceuticals: Generic] is valued at $2.53B. BNXTF’s [@Pharmaceuticals: Generic] market capitalization is $75.47M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green whileBNXTF’s FA Score has 0 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • BNXTF’s FA Score: 0 green, 5 red.
According to our system of comparison, ALVO is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 4 TA indicator(s) are bullish while BNXTF’s TA Score has 4 bullish TA indicator(s).

  • ALVO’s TA Score: 4 bullish, 4 bearish.
  • BNXTF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ALVO and BNXTF are a bad buy in the short-term.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +3.84% price change this week, while BNXTF (@Pharmaceuticals: Generic) price change was +10.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +2.88%. For the same industry, the average monthly price growth was +23.85%, and the average quarterly price growth was +67.10%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+2.88% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($2.53B) has a higher market cap than BNXTF($75.5M). BNXTF YTD gains are higher at: 151.846 vs. ALVO (-38.624). ALVO has higher annual earnings (EBITDA): 207M vs. BNXTF (-4.93M). ALVO has more cash in the bank: 151M vs. BNXTF (4.24K). BNXTF has less debt than ALVO: BNXTF (7.06M) vs ALVO (1.27B). ALVO has higher revenues than BNXTF: ALVO (560M) vs BNXTF (21.7K).
ALVOBNXTFALVO / BNXTF
Capitalization2.53B75.5M3,351%
EBITDA207M-4.93M-4,201%
Gain YTD-38.624151.846-25%
P/E Ratio35.30N/A-
Revenue560M21.7K2,580,645%
Total Cash151M4.24K3,563,842%
Total Debt1.27B7.06M17,950%
FUNDAMENTALS RATINGS
BNXTF: Fundamental Ratings
BNXTF
OUTLOOK RATING
1..100
86
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALVOBNXTF
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
48%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
40%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 1 day ago
69%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSADF23.44N/A
N/A
MS&AD Insurance Group Holdings, Inc.
NWKHY7.17N/A
N/A
Netcare, Ltd.
PNXPF0.03N/A
N/A
Planet Ventures Inc
HSHZY9.48N/A
N/A
Hoshizaki Corporation
ABMBF0.07-0.01
-7.66%
Abcourt Mines Inc.

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-5.36%
EBS - ALVO
26%
Poorly correlated
+5.43%
CRON - ALVO
22%
Poorly correlated
-2.58%
ACB - ALVO
22%
Poorly correlated
-4.44%
PBH - ALVO
21%
Poorly correlated
-0.84%
CURLF - ALVO
21%
Poorly correlated
-6.87%
More

BNXTF and

Correlation & Price change

A.I.dvisor tells us that BNXTF and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNXTF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
N/A
TAK - BNXTF
32%
Poorly correlated
-2.07%
SNOA - BNXTF
29%
Poorly correlated
-0.49%
SDZXF - BNXTF
29%
Poorly correlated
N/A
ALVO - BNXTF
13%
Poorly correlated
-5.36%
ESAIY - BNXTF
11%
Poorly correlated
-2.50%
More